외상 후 스트레스 장애(PTSD) 출시 및 파이프라인 약제 평가, 임상시험, 경쟁 구도
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
상품코드
:
1327432
리서치사
:
GlobalData
발행일
:
2023년 07월
페이지 정보
:
영문 76 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
외상 후 스트레스 장애(PTSD) 치료제의 현재 및 향후 경쟁 구도에 대해 조사했으며, 시장에 영향을 미칠 가능성이 있는 주요 동향, 경쟁 구도, 강력한 제품 포트폴리오를 가진 신규 참여 기업의 우위성 등에 대해 데이터에 기반한 개요를 제공하고 있습니다.
목차
제1장 서문
제2장 주요 조사 결과
제3장 질병 상황
제4장 시판약 평가
- 주요 시판약
- 작용기서별 개요
- 투여 경로별 개요
- 시판약 개요와 판매 예측
제5장 가격결정과 상환 평가
제6장 파이프라인 의약품 평가
- 제III상 파이프라인 의약품
- 개발 단계별 개요
- 분자 유형별 개요
- 작용기서별 개요
- 투여 경로별 개요
- 의약품 특이적 상전이 성공률(PTSR)과 승인의 가능성(LoA)
- 치료 영역 및 적응증 고유 PTSR 및 LoA
제7장 임상시험 평가
- 역사적 개요
- 단계별 개요
- 현황별 개요
- 진행중 및 계획중인 시험 단계별 개요
- 가상 컴포넌트를 사용한 임상시험
- 지역적 개요
- 지역별 단일국 및 다국적 시험
- 스폰서 상위 20사와 단계별 내역
- 스폰서 상위 20사의 현황별 내역
- 엔드포인트 현황별 개요
- 인종 및 민족별 개요
- 등록 데이터
- 임상시험 사이트 상위 20개국
- 세계의 TOP 20 사이트
- 실현 가능성 분석 - 지역적 개요
- 실현 가능성 분석 - 벤치마크 모델
제8장 거래 상황
- 지역별 합병, 인수, 전략적 제휴
- 최근 합병, 인수, 전략적 제휴
제9장 상업적 평가
제10장 향후 시장 촉진요인
제11장 부록
KSA
영문 목차
Abstract
This reports provides a data-driven overview of the current and future competitive landscape in PTSD therapeutics.
Scope
GlobalData's PTSD: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include -
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the PTSD market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global PTSD market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Table of Contents
1 Preface
- 1.1 Contents
- 1.2 Report Scope
- 1.3 List of Tables and Figures
- 1.4 Abbreviations
2 Key Findings
3 Disease Landscape
- 3.1 Disease Overview
- 3.2 Epidemiology Overview
- 3.3 Treatment Overview
4 Marketed Drugs Assessment
- 4.1 Leading Marketed Drugs
- 4.2 Overview by Mechanism of Action
- 4.3 Overview by Route of Administration
- 4.4 Marketed Drugs Profiles and Sales Forecasts
5 Pricing and Reimbursement Assessment
- 5.1 Annual Therapy Cost
- 5.2 Time to Pricing and Reimbursement
6 Pipeline Drugs Assessment
- 6.1 Phase III Pipeline Drugs
- 6.2 Overview by Development Stage
- 6.3 Overview by Molecule Type
- 6.4 Overview by Mechanism of Action
- 6.5 Overview by Route of Administration
- 6.6 Drug Specific Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA)
- 6.7 Therapy Area and Indication-specific PTSR and LoA
7 Clinical Trials Assessment
- 7.1 Historical Overview
- 7.2 Overview by Phase
- 7.3 Overview by Status
- 7.4 Overview by Phase for Ongoing and Planned Trials
- 7.5 Trials with Virtual Components
- 7.6 Geographic Overview
- 7.7 Single-Country and Multinational Trials by Region
- 7.8 Top 20 Sponsors with Breakdown by Phase
- 7.9 Top 20 Sponsors with Breakdown by Status
- 7.10 Overview by Endpoint Status
- 7.11 Overview by Race and Ethnicity
- 7.12 Enrollment Data
- 7.13 Top 20 countries for Trial Sites
- 7.14 Top 20 Sites Globally
- 7.15 Feasibility Analysis - Geographic Overview
- 7.16 Feasibility Analysis - Benchmark Models
8 Deals Landscape
- 8.1 Mergers, Acquisitions, and Strategic Alliances by Region
- 8.2 Recent Mergers, Acquisitions, and Strategic Alliances
9 Commercial Assessment
10 Future Market Catalysts
11 Appendix
- 11.1 Methodology
- 11.2 Methodology - Sales Forecast
- 11.3 Methodology - Pricing and Reimbursement
- 11.4 Methodology - PTSR and LoA Analysis
- 11.5 About the Authors
- 11.6 Contact Us
- 11.7 Disclaimer
관련자료
